About us

Our diverse, multidisciplinary team brings together dedicated clinicians, experienced industry leaders, and published academic experts. Together, we share proven expertise in engineering, medicine and manufacturing that creates innovative solutions for caregivers and patients.

Our story

A collaboration between clinicians and visionary technologists reimagined the management of cardiovascular diseases. University research and early collaborations established the requirements for our data systems and the patented technologies that form the foundation of our wearable devices and analysis algorithms. Today we are commercialising our innovations, soon we will have unique and proprietary clinical data sets. This will enable Precision and its partners to revolutionise the management of cardiovascular diseases.

Our leadership team

Mohamed Abou-Alam Executive Director, CEO International venture fund partner, health and sustainability

Dr David Hampton COO 30 years commercialisation; Medtronic and 3 successful start-ups

Prof. Sir Magdi Yacoub Clinical Director Pioneering heart transplant surgeon and innovator

Prof. Chris McLeod Scientific Director Imperial College London Professor and specialist in implantable biomedical monitoring

Dr. Reza Bahmanyar Research Director Micro-miniature sensor and SAW technology inventor at Imperial College London

Development timeline

• 2002Conceptualization of cardiac management system
• 2003Start of PhD research and academic collaboration to develop patient sensors
  First patent application for using SAW technology as a cardiac implant
• 2008Extended translational development within a fully funded programme at Imperial College
• 2009Begin specific design refinements for eventual application to Chronic Heart Failure
• 2012Wellcome Trust and UK Health & Social Care funding expands laboratory studies
• 2015First animal implantation to monitor cardiac pressures and verify performance
• 2018Commercialisation development begins to complete the remote monitoring system design
  Successful acute trial demonstrating successful endovascular deployment and wireless monitoring
• 2021Creation of Precision Cardiovascular
• 2022Successful acute study of Precision’s system validating design readiness for production